Sarepta Therapeutics, Inc. (SRPT)

Stock News iRobot enters Chapter 11: iRobot (IRBT) filed for Chapter 11 and agreed to be acquired by contract manufacturer Picea Robotics, saying operations and...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it has entered into separate, privately ne...

Federated Hermes Inc. grew its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 347.8% during the second quarter, according to its most recent Form 13F filing with the Securities and...

Sarepta Therapeutics (SRPT) is getting a fresh vote of confidence from Wedbush, which initiated coverage with an Outperform rating, arguing the stock's selloff...

Sarepta Therapeutics (SRPT) is getting a fresh vote of confidence from Wedbush, which initiated coverage with an Outperform rating, arguing the stock's selloff...

Dyne Therapeutics reported positive results from Phase 1/2 DELIVER trial for z-rostudirsen in DMD amenable to exon 51 skipping....

Edgestream Partners L.P. lifted its position in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 870.3% in the second quarter, according to the company in its most recent 13F filing with the Sec...

Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock?...

Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 10.6% in the second quarter, according to its most recent F...

Envestnet Asset Management Inc. lessened its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) by 33.1% in the second quarter, according to the company in its most recent Form 13F filing wi...